These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 7146618)

  • 1. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
    Schweitzer JW; Schwartz R; Friedhoff AJ
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):21-30. PubMed ID: 7146618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM; Matvienko OA; Nurk AM
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging and the regulation of striatal dopaminergic mechanisms in mice.
    Randall PK; Severson JA; Finch CE
    J Pharmacol Exp Ther; 1981 Dec; 219(3):695-700. PubMed ID: 7197719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic haloperidol does not increase specific dopamine receptor binding in rat frontal cortex.
    Meller E; Bohmaker K; Rosengarten H; Friedhoff AJ
    Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):323-32. PubMed ID: 7178646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine binding following prolonged haloperidol pretreatment.
    Hitri A; Weiner WJ; Borison RL; Diamond BI; Nausieda PA; Klawans HL
    Ann Neurol; 1978 Feb; 3(2):134-40. PubMed ID: 655662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic haloperidol treatment on stimulated synaptic overflow of dopamine in the rat striatum.
    Wiedemann DJ; Garris PA; Near JA; Wightman RM
    J Pharmacol Exp Ther; 1992 May; 261(2):574-9. PubMed ID: 1533666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal dopamine receptor supersensitivity after long-term haloperidol treatment of hypophysectomized rats.
    DeLucia R; Scavone C; Camillo MA
    Braz J Med Biol Res; 1989; 22(6):741-3. PubMed ID: 2620186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation by pergolide of haloperidol-induced striatal dopamine receptor density.
    Koller WC
    J Clin Psychopharmacol; 1984 Dec; 4(6):343-5. PubMed ID: 6512004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloperidol-induced behavioral supersensitivity is increased by monosialoganglioside treatment in rats without affecting spiroperidol-binding.
    Schröder U; Schröder H; Augustin W; Sabel BA
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1193-6. PubMed ID: 7996425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related changes in rat brain dopaminergic receptors.
    Petkov VV; Petkov VD; Grahovska T; Konstantinova E
    Acta Physiol Pharmacol Bulg; 1984; 10(4):16-27. PubMed ID: 6535368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of haloperidol-induced dopamine receptor supersensitivity on kindled seizure development.
    Gee KW; Killam EK; Hollinger MA
    J Pharmacol Exp Ther; 1983 Apr; 225(1):70-6. PubMed ID: 6834278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.
    Akiyama K; Sato M; Kashihara K; Otsuki S
    Biol Psychiatry; 1982 Dec; 17(12):1389-402. PubMed ID: 7159638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
    Meller E; Bohmaker K; Goldstein M; Schweitzer JW; Friedhoff AJ
    Eur J Pharmacol; 1985 Mar; 109(3):389-94. PubMed ID: 3157587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
    Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced striatal 3H-spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phase.
    Bhargava HN
    Life Sci; 1984 Feb; 34(9):873-9. PubMed ID: 6142397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postsynaptic location of acrylamide-induced modulation of striatal 3H-spiroperidol binding.
    Hong JS; Tilson HA; Agrawal AK; Karoum F; Bondy SC
    Neurotoxicology; 1982 Jul; 3(1):108-12. PubMed ID: 6890181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic domperidone fails to increase striatal spiperone binding sites despite hyperprolactinemia: comparison with chronic haloperidol.
    Morgan DG; Sinha YN; Finch CE
    Neuroendocrinology; 1984 May; 38(5):407-10. PubMed ID: 6728123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the time course of haloperidol-induced up-regulation of rat striatal and mesolimbic dopamine receptors.
    Prosser ES; Csernansky JG; Hollister LE
    Life Sci; 1988; 43(8):715-20. PubMed ID: 2901023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
    Gordon JH; Diamond BI
    Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual differences in the response of dopamine receptor number to chronic haloperidol treatment.
    Bannet J; Belmaker RH; Ebstein RP
    Biol Psychiatry; 1981 Nov; 16(11):1059-65. PubMed ID: 7349620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.